<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38696415</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>30</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Biases and limitations in observational studies of Long COVID prevalence and risk factors: A rapid systematic umbrella review.</ArticleTitle><Pagination><StartPage>e0302408</StartPage><MedlinePgn>e0302408</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0302408</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0302408</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Observational studies form the foundation of Long COVID knowledge, however combining data from Long COVID observational studies has multiple methodological challenges. This umbrella review synthesizes estimates of Long COVID prevalence and risk factors as well as biases and limitations in the primary and review literatures.</AbstractText><AbstractText Label="METHODS AND FINDINGS" NlmCategory="RESULTS">A systematic literature search was conducted using multiple electronic databases (PubMed, EMBASE, LitCOVID) from Jan 1, 2019 until June 9, 2023. Eligible studies were systematic reviews including adult populations assessed for at least one Long COVID symptom four weeks or more after SARS-CoV-2 infection. Overall and subgroup prevalence and risk factors as well as risk of bias (ROB) assessments were extracted and descriptively analyzed. The protocol was registered with PROSPERO (CRD42023434323). Fourteen reviews of 5-196 primary studies were included: 8 reported on Long COVID prevalence, 5 on risk/protective factors, and 1 on both. Prevalence of at least 1 Long COVID symptom ranged from 21% (IQR: 8.9%-35%) to 74.5% (95% CI: 55.6%-78.0%). Risk factor reviews found significant associations between vaccination status, sex, acute COVID-19 severity, and comorbidities. Both prevalence and risk factor reviews frequently identified selection and ascertainment biases. Using the AMSTAR 2 criteria, the quality of included reviews, particularly the prevalence reviews, were concerning for the adequacy of ROB assessments and justifications for conducting meta-analysis.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">A high level of heterogeneity render the interpretation of pooled prevalence estimates of Long COVID challenging, further hampered by the lack of robust critical appraisals in the included reviews. Risk factor reviews were of higher quality overall and suggested consistent associations between Long COVID risk and patient characteristics.</AbstractText><CopyrightInformation>Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hua</LastName><ForeName>Miao Jenny</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-8845-1185</Identifier><AffiliationInfo><Affiliation>Office of the Assistant Secretary of Planning and Evaluation, U.S. Department of Health and Human Services, Washington, DC, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butera</LastName><ForeName>Gisela</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3976-0018</Identifier><AffiliationInfo><Affiliation>National Institutes of Health Library, Office of Research Services, U.S. Department of Health and Human Services, Bethesda, MD, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akinyemi</LastName><ForeName>Oluwaseun</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Office of the Assistant Secretary of Planning and Evaluation, U.S. Department of Health and Human Services, Washington, DC, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Porterfield</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Office of the Assistant Secretary of Planning and Evaluation, U.S. Department of Health and Human Services, Washington, DC, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064887" MajorTopicYN="Y">Observational Studies as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015982" MajorTopicYN="N">Bias</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>2</Day><Hour>18</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>2</Day><Hour>18</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>2</Day><Hour>13</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38696415</ArticleId><ArticleId IdType="pmc">PMC11065234</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0302408</ArticleId><ArticleId IdType="pii">PONE-D-23-43411</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McGrath LJ, Scott AM, Surinach A, Chambers R, Benigno M, Malhotra D. Use of the Postacute Sequelae of COVID-19 Diagnosis Code in Routine Clinical Practice in the US. JAMA Network Open. 2022;5(10):e2235089. doi: 10.1001/jamanetworkopen.2022.35089</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.35089</ArticleId><ArticleId IdType="pmc">PMC9539719</ArticleId><ArticleId IdType="pubmed">36201207</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133&#x2013;46. Epub 20230113. doi: 10.1038/s41579-022-00846-2 ; PubMed Central PMCID: PMC9839201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al.. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. Epub 20210809. doi: 10.1038/s41598-021-95565-8 ; PubMed Central PMCID: PMC8352980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med. 2022;28(11):2398&#x2013;405. doi: 10.1038/s41591-022-02051-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Burden of Disease Long CC, Wulf Hanson S, Abbafati C, Aerts JG, Al-Aly Z, Ashbaugh C, et al.. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328(16):1604. doi: 10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al.. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. eClinicalMedicine. 2023;55. doi: 10.1016/j.eclinm.2022.101762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro F, Belati A, Tulone O, Diella L, Fiore Bavaro D, Bonica R, et al.. Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients. Intern Emerg Med. 2022. doi: 10.1007/s11739-022-03164-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11739-022-03164-w</ArticleId><ArticleId IdType="pmc">PMC9709360</ArticleId><ArticleId IdType="pubmed">36449260</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al.. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008&#x2013;12. doi: 10.1001/jama.283.15.2008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.15.2008</ArticleId><ArticleId IdType="pubmed">10789670</ArticleId></ArticleIdList></Reference><Reference><Citation>Metelli S, Chaimani A. Challenges in meta-analyses with observational studies. Evid Based Ment Health. 2020;23(2):83&#x2013;7. Epub 20200305. doi: 10.1136/ebmental-2019-300129 ; PubMed Central PMCID: PMC10231593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ebmental-2019-300129</ArticleId><ArticleId IdType="pmc">PMC10231593</ArticleId><ArticleId IdType="pubmed">32139442</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirt J, Janiaud P, Gloy VL, Schandelmaier S, Pereira TV, Contopoulos-Ioannidis D, et al.. Robustness of reported postacute health outcomes in children with SARS-CoV-2 infection: a systematic review. Arch Dis Child. 2023;108(6):498&#x2013;505. Epub 20220902. doi: 10.1136/archdischild-2022-324455 ; PubMed Central PMCID: PMC10314012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2022-324455</ArticleId><ArticleId IdType="pmc">PMC10314012</ArticleId><ArticleId IdType="pubmed">36719840</ArticleId></ArticleIdList></Reference><Reference><Citation>Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis. JBI; 2020.</Citation></Reference><Reference><Citation>Khangura S, Konnyu K, Cushman R, Grimshaw J, Moher D. Evidence summaries: the evolution of a rapid review approach. Syst Rev. 2012;1:10. Epub 20120210. doi: 10.1186/2046-4053-1-10 ; PubMed Central PMCID: PMC3351736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2046-4053-1-10</ArticleId><ArticleId IdType="pmc">PMC3351736</ArticleId><ArticleId IdType="pubmed">22587960</ArticleId></ArticleIdList></Reference><Reference><Citation>Garritty C, Gartlehner G, Nussbaumer-Streit B, King VJ, Hamel C, Kamel C, et al.. Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews. J Clin Epidemiol. 2021;130:13&#x2013;22. Epub 20201015. doi: 10.1016/j.jclinepi.2020.10.007 ; PubMed Central PMCID: PMC7557165.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2020.10.007</ArticleId><ArticleId IdType="pmc">PMC7557165</ArticleId><ArticleId IdType="pubmed">33068715</ArticleId></ArticleIdList></Reference><Reference><Citation>Tricco AC, Antony J, Zarin W, Strifler L, Ghassemi M, Ivory J, et al.. A scoping review of rapid review methods. BMC Med. 2015;13:224. Epub 20150916. doi: 10.1186/s12916-015-0465-6 ; PubMed Central PMCID: PMC4574114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-015-0465-6</ArticleId><ArticleId IdType="pmc">PMC4574114</ArticleId><ArticleId IdType="pubmed">26377409</ArticleId></ArticleIdList></Reference><Reference><Citation>Department of Health and Human Services OotASfH. National Research Action Plan on Long COVID. 2022.</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, Condition WHOCCDWGoP-C-. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;e7. Epub 20211221. doi: 10.1016/S1473-3099(21)00703-9 ; PubMed Central PMCID: PMC8691845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al.. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. Epub 20170921. doi: 10.1136/bmj.j4008 ; PubMed Central PMCID: PMC5833365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.j4008</ArticleId><ArticleId IdType="pmc">PMC5833365</ArticleId><ArticleId IdType="pubmed">28935701</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmati M, Udeh R, Yon DK, Lee SW, Dolja-Gore X, Mc EM, et al.. A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences. J Med Virol. 2023;95(6):e28852. doi: 10.1002/jmv.28852 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28852</ArticleId><ArticleId IdType="pubmed">37288652</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Notarte KI, Peligro PJ, Velasco JV, Ocampo MJ, Henry BM, et al.. Long-COVID Symptoms in Individuals Infected with Different SARS-CoV-2 Variants of Concern: A Systematic Review of the Literature. Viruses. 2022;14(12):2629. doi: 10.3390/v14122629</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14122629</ArticleId><ArticleId IdType="pmc">PMC9785120</ArticleId><ArticleId IdType="pubmed">36560633</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q, Jia M, Sun Y, Jiang B, Cui D, Feng L, et al.. One-Year Temporal Changes in Long COVID Prevalence and Characteristics: A Systematic Review and Meta-Analysis. Value Health. 2022:S1098&#x2013;3015(22)04743-X. doi: 10.1016/j.jval.2022.11.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jval.2022.11.011</ArticleId><ArticleId IdType="pubmed">36436792</ArticleId></ArticleIdList></Reference><Reference><Citation>Nittas V, Gao M, West EA, Ballouz T, Menges D, Wulf Hanson S, et al.. Long COVID Through a Public Health Lens: An Umbrella Review. Public Health Rev. 2022;0. doi: 10.3389/phrs.2022.1604501</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/phrs.2022.1604501</ArticleId><ArticleId IdType="pmc">PMC8963488</ArticleId><ArticleId IdType="pubmed">35359614</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng N, Zhao YM, Yan W, Li C, Lu QD, Liu L, et al.. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol Psychiatry. 2023;28(1):423&#x2013;33. Epub 20220606. doi: 10.1038/s41380-022-01614-7 ; PubMed Central PMCID: PMC9168643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01614-7</ArticleId><ArticleId IdType="pmc">PMC9168643</ArticleId><ArticleId IdType="pubmed">35668159</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y, Deng J, Liu Q, Du M, Liu M, Liu J. Long-Term Consequences of Asymptomatic SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2023;20(2):1613. doi: 10.3390/ijerph20021613</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20021613</ArticleId><ArticleId IdType="pmc">PMC9863678</ArticleId><ArticleId IdType="pubmed">36674367</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasserie T, Hittle M, Goodman SN. Assessment of the Frequency and Variety of Persistent Symptoms Among Patients With COVID-19: A Systematic Review. JAMA Netw Open. 2021;4(5):e2111417. Epub 20210503. doi: 10.1001/jamanetworkopen.2021.11417 ; PubMed Central PMCID: PMC8155823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.11417</ArticleId><ArticleId IdType="pmc">PMC8155823</ArticleId><ArticleId IdType="pubmed">34037731</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al.. Risk Factors Associated With Post-COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern Med. 2023;183(6):566&#x2013;80. doi: 10.1001/jamainternmed.2023.0750 ; PubMed Central PMCID: PMC10037203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P. Effect of covid-19 vaccination on long covid: systematic review. BMJ Medicine. 2023;2(1). doi: 10.1136/bmjmed-2022-000385</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe A, Iwagami M, Yasuhara J, Takagi H, Kuno T. Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis. Vaccine. 2023;41(11):1783&#x2013;90. Epub 20230208. doi: 10.1016/j.vaccine.2023.02.008 ; PubMed Central PMCID: PMC9905096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.008</ArticleId><ArticleId IdType="pmc">PMC9905096</ArticleId><ArticleId IdType="pubmed">36774332</ArticleId></ArticleIdList></Reference><Reference><Citation>Pillay J, Rahman S, Guitard S, Wingert A, Hartling L. Risk factors and preventive interventions for post Covid-19 condition: systematic review. Emerg Microbes Infect. 2022;11(1):2762&#x2013;80. doi: 10.1080/22221751.2022.2140612 ; PubMed Central PMCID: PMC9665097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2140612</ArticleId><ArticleId IdType="pmc">PMC9665097</ArticleId><ArticleId IdType="pubmed">36302216</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, de Oliveira MHS, Peligro PJ, Velasco JV, Macaranas I, Ver AT, et al.. Age, Sex and Previous Comorbidities as Risk Factors Not Associated with SARS-CoV-2 Infection for Long COVID-19: A Systematic Review and Meta-Analysis. J Clin Med. 2022;11(24). Epub 20221209. doi: 10.3390/jcm11247314 ; PubMed Central PMCID: PMC9787827.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11247314</ArticleId><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells G, Shea B, O&#x2019;Connell D, Peterson J, Welch V, Losos M, et al.. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2015 [November
1, 2023]. Available from: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.</Citation></Reference><Reference><Citation>National Heart Lung and Blood Institute. Study quality assessment tools 2021 [11/20/2023]. Available from: https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools.</Citation></Reference><Reference><Citation>Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al.. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934&#x2013;9. Epub 20120627. doi: 10.1016/j.jclinepi.2011.11.014 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2011.11.014</ArticleId><ArticleId IdType="pubmed">22742910</ArticleId></ArticleIdList></Reference><Reference><Citation>Rostom A, Dube C, Cranney A, Saloojee N, Sy R, Garritty C, et al.. Celiac disease. Evid Rep Technol Assess (Summ). 2004;(104):1&#x2013;6. ; PubMed Central PMCID: PMC4781297.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4781297</ArticleId><ArticleId IdType="pubmed">15346868</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al.. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. Epub 20161012. doi: 10.1136/bmj.i4919 ; PubMed Central PMCID: PMC5062054.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.i4919</ArticleId><ArticleId IdType="pmc">PMC5062054</ArticleId><ArticleId IdType="pubmed">27733354</ArticleId></ArticleIdList></Reference><Reference><Citation>Tufanaru C, Munn Z, Aromataris E, Campbell J, Hopp L. Chapter 3: Systematic reviews of effectiveness. 2020. In: JBI Manual for Evidence Synthesis [Internet].
JBI. Available from: https://synthesismanual.jbi.global.</Citation></Reference><Reference><Citation>Hayden JA, van der Windt DA, Cartwright JL, Cote P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158(4):280&#x2013;6. doi: 10.7326/0003-4819-158-4-201302190-00009 .</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-158-4-201302190-00009</ArticleId><ArticleId IdType="pubmed">23420236</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009;172(1):137&#x2013;59. doi: 10.1111/j.1467-985X.2008.00552.x ; PubMed Central PMCID: PMC2667312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1467-985X.2008.00552.x</ArticleId><ArticleId IdType="pmc">PMC2667312</ArticleId><ArticleId IdType="pubmed">19381330</ArticleId></ArticleIdList></Reference><Reference><Citation>Imrey PB. Limitations of Meta-analyses of Studies With High Heterogeneity. JAMA Netw Open. 2020;3(1):e1919325. Epub 20200103. doi: 10.1001/jamanetworkopen.2019.19325 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2019.19325</ArticleId><ArticleId IdType="pubmed">31922554</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J Infect Dis. 2022;226(9):1593&#x2013;607. doi: 10.1093/infdis/jiac136 ; PubMed Central PMCID: PMC9047189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al.. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Network Open. 2021;4(10):e2128568. doi: 10.1001/jamanetworkopen.2021.28568</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodrow M, Carey C, Ziauddeen N, Thomas R, Akrami A, Lutje V, et al.. Systematic Review of the Prevalence of Long COVID. Open Forum Infect Dis. 2023;10(7):ofad233. Epub 20230503. doi: 10.1093/ofid/ofad233 ; PubMed Central PMCID: PMC10316694.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofad233</ArticleId><ArticleId IdType="pmc">PMC10316694</ArticleId><ArticleId IdType="pubmed">37404951</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford ND, Slaughter D, Edwards D, Dalton A, Perrine C, Vahratian A, et al.. Long COVID and Significant Activity Limitation Among Adults, by Age&#x2014;United States, June 1&#x2013;13, 2022, to June 7&#x2013;19, 2023. MMWR Morb Mortal Wkly Rep. 2023;72(32):866&#x2013;70. Epub 20230811. doi: 10.15585/mmwr.mm7232a3 ; PubMed Central PMCID: PMC10415000.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7232a3</ArticleId><ArticleId IdType="pmc">PMC10415000</ArticleId><ArticleId IdType="pubmed">37561665</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith GJ, Morris TT, Tudball MJ, Herbert A, Mancano G, Pike L, et al.. Collider bias undermines our understanding of COVID-19 disease risk and severity. Nat Commun. 2020;11(1):5749. doi: 10.1038/s41467-020-19478-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19478-2</ArticleId><ArticleId IdType="pmc">PMC7665028</ArticleId><ArticleId IdType="pubmed">33184277</ArticleId></ArticleIdList></Reference><Reference><Citation>Murad MH, Asi N, Alsawas M, Alahdab F. New evidence pyramid. Evid Based Med. 2016;21(4):125&#x2013;7. Epub 20160623. doi: 10.1136/ebmed-2016-110401 ; PubMed Central PMCID: PMC4975798.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ebmed-2016-110401</ArticleId><ArticleId IdType="pmc">PMC4975798</ArticleId><ArticleId IdType="pubmed">27339128</ArticleId></ArticleIdList></Reference><Reference><Citation>Office of National Statistics. Technical article: Updated estimates of the prevalence of post-acute symptoms among people with coronavirus (COVID-19) in the UK: 26 April 2020 to 1 August 2021 2021 [25 October 2023]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/technicalarticleupdatedestimatesoftheprevalenceofpostacutesymptomsamongpeoplewithcoronaviruscovid19intheuk/26april2020to1august2021.</Citation></Reference><Reference><Citation>National Academies of Science, Engineering, and Medicine. Examining the Working Definition for Long COVID n.d. [12/13/2023]. Available from: https://www.nationalacademies.org/our-work/examining-the-working-definition-for-long-covid.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>